Evidence map›Paper›PMID 35205257›Full record

ReviewGenes2022

Expanding the Clinical Phenotype of 19q Interstitial Deletions: A New Case with 19q13.32-q13.33 Deletion and Short Review of the Literature.

Elena-Silvia Shelby, Michael Morris, Liliana Pădure, Andrada Mirea, Relu Cocoș, Alexandru Cărămizaru, Simona Șerban-Sosoi, Andrei Pîrvu, Ioana Streață

Open access · goldAbstract readCase ReportsReview
In one paragraph

Review in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Elena-Silvia ShelbyNational University Center for Children's Neurorehabilitation "Dr. Nicolae Robănescu", 44 Dumitru Mincă Street, District 4, 041408 Bucharest, Romania.ORCID 0000-0003-4658-2416
Michael MorrisDepartment of Genetics, SYNLAB Switzerland, Chemin d'Entre-Bois 21, 1018 Lausanne, Switzerland.
Liliana PădureNational University Center for Children's Neurorehabilitation "Dr. Nicolae Robănescu", 44 Dumitru Mincă Street, District 4, 041408 Bucharest, Romania.
Andrada MireaNational University Center for Children's Neurorehabilitation "Dr. Nicolae Robănescu", 44 Dumitru Mincă Street, District 4, 041408 Bucharest, Romania.
Relu CocoșChair of Medical Genetics, University of Medicine and Pharmacy "Carol Davila", 37 Dionisie Lupu Street, 020021 Bucharest, Romania.
Alexandru CărămizaruHuman Genomics Laboratory, Craiova University of Medicine and Pharmacy, 2-4 Petru Rareș Street, 200349 Craiova, Romania.
Simona Șerban-SosoiHuman Genomics Laboratory, Craiova University of Medicine and Pharmacy, 2-4 Petru Rareș Street, 200349 Craiova, Romania.
Andrei PîrvuHuman Genomics Laboratory, Craiova University of Medicine and Pharmacy, 2-4 Petru Rareș Street, 200349 Craiova, Romania.
Ioana StreațăHuman Genomics Laboratory, Craiova University of Medicine and Pharmacy, 2-4 Petru Rareș Street, 200349 Craiova, Romania.
University of Medicine and Pharmacy of Craiova · ROCarol Davila University of Medicine and Pharmacy · ROCenter for Children · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

19q13 microdeletion syndrome is a very rare genetic disease characterized by pre- and postnatal growth retardation, intellectual disability, expressive language impairment, ectodermal dysplasia, and slender habitus. Since the description of the first case in 1998, less than 30 cases have been reported worldwide. This article aims to review the knowledge gathered so far on this subject and to present the case of a 10-year-old girl admitted to the National University Center for Children Neurorehabilitation "Dr. Nicolae Robanescu" in November of 2018 who presented a slender habitus, growth retardation, facial dysmorphism, skeletal abnormalities, and ectodermal dysplasia. Array-CGH analysis revealed a 1.53 Mb deletion in the 19q13.32-q13.33 region. MLPA for the FKRP gene revealed that the microdeletion was de novo. The patient's phenotype overlapped with the clinical features of 19q13 microdeletion syndrome. To our knowledge, this is the first case of 19q13 microdeletion syndrome to ever be reported in Romania. We believe our case presents additional features that have never been previously reported in this syndrome, namely, dilatation of the third ventricle and subependymal cyst, left iris coloboma, and tracheomalacia. Moreover, unlike the other 19q13 microdeletion cases that presented with dystonia, our patient also presented dystonia but, interestingly, without having haploinsufficiency of the KMT2B gene.

Indexed as

DystoniaEctodermal DysplasiaChromosome DeletionComparative Genomic HybridizationGrowth DisordersHumansPentosyltransferasesPhenotypeSyndromeFKRP protein, humanPentosyltransferases19q13 microdeletion syndromearray-CGHcontiguous gene syndrome

Identifiers

PMID35205257
PMCPMC8872157
OpenAlexW4210597696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.